Paul de Souza COSA-IPOS Joint Scientific Meeting 2012

Abstracts this author is presenting:

• Abiraterone acetate (AA) in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer (mCRPC): results of interim analysis (IA) of COU-AA-302, a randomized phase 3 study — COSA Best of the Best Orals: Clinical Sciences